CD163 and sclerosing cholangitis: In 2016 the role of sCD163 in autoimmune liver disorders was first investigated in 121 patients: 101 had AIH type-1; 13 had variant syndromes of AIH type-1; primary biliary cholangitis; 7 of AIH type-1 and primary sclerosing cholangitis (60).